Related Experiment Video
Updated: Jun 25, 2026
07:59
Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Translational research in hormone-related cancer
Luisa M Massimo1, Gian Paolo Tonini
1Department of Pediatric Hematology and Oncology, G. Gaslini Children's Research Hospital, Genova, Italy. luisamassimo@ospedale-gaslini.ge.it
Annals of the New York Academy of Sciences
|March 3, 2009
Summary
Steroid hormones influence cancer development, with new techniques like comparative genomic hybridization array and gene expression profiling revealing insights into hormone-cancer relationships and potential therapeutic targets. MicroRNA research further illuminates gene regulation in hormone-related cancers.
Area of Science:
- Oncology
- Endocrinology
- Genomics
Background:
- Hormones play a role in various cancers, but their specific mechanisms in carcinogenesis are not fully understood.
- Advancements in technology allow for direct study of hormone-cancer relationships, including genomic abnormalities.
Purpose of the Study:
- To explore the biological mechanisms of hormone-cancer relationships using advanced genomic and transcriptomic approaches.
- To identify potential "cancer signatures" and understand the role of steroids in carcinogenesis.
- To investigate the role of microRNA in gene expression regulation within hormone-related cancers.
Main Methods:
- Comparative genomic hybridization array (aCGH) for detecting genome abnormalities.
- Gene expression profiling to identify "cancer signatures" and steroid roles.
- Analysis of microRNA in gene expression regulation.
Main Results:
- Genomic abnormalities and gene expression changes are associated with hormone-related cancers.
- MicroRNA offers new insights into the fine regulation of gene expression in cancer cells.
- Experimental models are being developed for rapid translation to treatment protocols.
Conclusions:
- Integrated genomic, transcriptomic, and microRNA analyses are crucial for understanding hormone-cancer interactions.
- Development of "labs on a microchip" for personalized prognosis and therapy is a key future goal.
- Patient stratification, particularly for high-risk individuals, is gaining importance in clinical research.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:29Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: